Individual Investor Lost Over 100% in Kolon TissueGene Investment
She stated that she bought TissueGene at around 100,000 won, entering the market after its peak of 149,000 won. However, she experienced a painful loss, losing her entire investment as the stock subsequently hit consecutive daily price limits.
This experience symbolically illustrates the risks that can arise when chasing rapidly rising stocks too late. When investors aggressively buy stocks that have already surged, they become vulnerable to unexpected negative events or market volatility, significantly increasing the potential for substantial losses.


